Clinical Trials Logo

Anastomotic Leak clinical trials

View clinical trials related to Anastomotic Leak.

Filter by:

NCT ID: NCT03997721 Completed - Fluid Overload Clinical Trials

Pathophysiology of Perioperative Fluid Management in Emergency Laparotomy

Start date: May 23, 2019
Phase:
Study type: Observational [Patient Registry]

Pathophysiology of perioperative fluid management in patients undergoing emergency laparotomy.

NCT ID: NCT03990714 Completed - Laparoscopy Clinical Trials

Intracorporeal Vs Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy

IVEA
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Objective. The aim of this study was to evaluate short-term outcomes of performing intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy for right colon neoplasm. Background. Despite advances in laparoscopic approach in colorectal surgery and the clear benefit of this approach over open surgery, the technical difficulty in performing intracorporeal anastomosis causes certain groups continue performing it extracorporeally in right colon surgery. Methods. This study was a prospective multicenter randomized trial with two parallel groups being done intracorporeal anastomosis (IA) or extracorporeal anastomosis (EA) in laparoscopic right hemicolectomy for right colon neoplasm, carried out between January 2016 and December 2018.

NCT ID: NCT03974672 Completed - Colorectal Cancer Clinical Trials

A T Drain Approach Treating Anastomotic Leaks After Gastrointestinal Surgery

TDRAIN
Start date: January 1, 2014
Phase:
Study type: Observational

Assessing the use of a T drain approach for an anastomotic leak after gastrointestinal surgery. The study's aim is to retrospectively assess the safety and benefits of this approach.

NCT ID: NCT03962244 Not yet recruiting - Leaks, Anastomotic Clinical Trials

Stent Therapy Versus Endoscopic Vacuum Therapy for Anastomotic Leaks After Esophagectomy

EsoLeak
Start date: May 1, 2021
Phase:
Study type: Observational

Exploratory study of the efficiency of endoscopic stenting versus endoscopic vacuum therapy in patients with intrathoracic esophago-gastric anastomotic leakage after oncological resection of the esophagus.

NCT ID: NCT03910699 Recruiting - Rectal Neoplasms Clinical Trials

THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer

THREESTAPLER
Start date: April 10, 2019
Phase: N/A
Study type: Interventional

This trial aims to assess safety and efficacy of three-row circular staplers compared to two-row surgical stapllers in short-term and long-term perspective in patients with rectal cancer undergoing low anterior resection with stapled colorectal anastomosis. All the patients will undergo a low anterior resection. In a half of patients a colorectal anastomosis will be created with a three-row surgical circular stapler. In another half of patients a colorectal anastomosis will be created with a two-row surgical circular stapler.

NCT ID: NCT03862378 Recruiting - Clinical trials for Gastrointestinal Cancer

Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis

APPEAL-GC
Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

In our previous study, a nomogram model was established to predict intra-abdominal infectious complications after gastrointestinal surgery. This model was based on the clinical data and the drainage fluid cytokine levels, and it received an AUC >0.9. In this study, validation of this nomogram is planned to be conducted in this prospective cohort study.

NCT ID: NCT03847857 Active, not recruiting - Clinical trials for Esophageal Anastomotic Leak

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

Start date: February 21, 2019
Phase: Phase 3
Study type: Interventional

The primary objective is to evaluate the efficacy and assess the role of Porcine Fibrin Sealant (Bioseal®) in preventing cervical anastomotic leakage after esophagectomy in the patients with resectable thoracic esophageal cancer and gastroesophageal junction cancer.

NCT ID: NCT03829098 Completed - Esophageal Cancer Clinical Trials

TreatmENT of AnastomotiC Leakage After Esophagectomy

TENTACLE
Start date: April 1, 2019
Phase:
Study type: Observational

Rationale: Anastomotic leakage (0% - 30%) is a severe complication after esophagectomy with mortality rates approximately ranging from 2% - 12%. In addition, it is associated with a prolonged ICU treatment and hospital stay. Anastomotic leakage severity is currently graded according to how it is treated (grade I: conservative treatment, grade II endoscopic or radiologic intervention and grade III surgical intervention). However, this scoring system cannot be used to guide decision making when anastomotic leakage is diagnosed in a clinical setting. Factors that may influence the severity of the anastomotic leakage are (amongst others) location of the anastomosis, estimated surface of the defect, estimated circumference of the defect, extent of contamination, degree of sepsis and time from diagnosis until therapy. However, little is known about to what extent these and other factors contribute to anastomotic leakage severity. In addition, there is a paucity of data on what leakage characteristics dictate the success of a specific treatment. Primary study objectives 1. To investigate what factors contribute to anastomotic leakage severity and to compose an evidence based anastomotic leakage severity score. 2. To investigate what anastomotic leakage characteristics are associated with success of different anastomotic leakage treatments and to compare the effectiveness of different initial anastomotic leakage treatments for leakages classified according to severity and leakage characteristics. Study design: International multicenter retrospective cohort study. Study population: Adult patients with anastomotic leakage after esophagectomy and gastric conduit reconstruction for esophageal cancer. Cohort size: 1000-2000 patients with anastomotic leakage after esophagectomy for cancer. Primary outcome parameter: 90 day mortality. Secondary outcome parameters: in-hospital mortality, 30-day mortality, 180-day mortality, comprehensive complications index, total number of reinterventions, hospital and ICU length of stay, hospital related costs. Funding: Radboudumc

NCT ID: NCT03828266 Recruiting - Clinical trials for Gastrointestinal Cancer

Prediction of Abdominal Complications After GastroEnterological Surgery

PACAGE
Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this multi-centered study is to understand the epidemiology of infectious complications after gastrointestinal surgery in China. In total, 17 centers from China will prospectively register their patients undergo gastric or colorectal surgeries. Patient demographic data, operation information, and postoperative data including the infectious complications and the outcomes will be registered. We expect to include 2000 gastric and 2000 colorectal patients within one year and the study is expected to be finished in 2020.

NCT ID: NCT03795467 Active, not recruiting - Anastomotic Leak Clinical Trials

Peripheral Perfusion Index, Haemoglobin and Blood Transfusion in Acute Surgical Patients

Start date: November 1, 2017
Phase:
Study type: Observational

The peripheral perfusion index (PPI) is a non-invasive, feasible measure of peripheral perfusion and, assumed, the overall circulation, which all patients are monitored by. This study is carried out to assess the association between values of PPI, haemoglobin and blood transfusion. Hypothetically, patients with low values of hb are more susceptible to a deteriorating circulation reflected in poorer PPI regardless of blood pressure and that resuscitation with blood products improves PPI measurements. Moreover, that patients with low values of PPI have more surgical complications and higher mortality.